Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Acquisitions: Thermo Fisher buys Colo. spectrometer maker
Mass Device
Thursday, January 3, 2013 - 3:33pm
tags:
M&A, Thermo Fisher, spectrometer
DOJ drops Medicare fraud case against Fresenius
Mass Device
Thursday, January 3, 2013 - 3:32pm
tags:
Medicare, fraud, Fresenius, legal, lawsuit
Cardiologist: Boston Scientific's S-ICD requires further trials
FierceMedicalDevice
Thursday, January 3, 2013 - 3:23pm
tags:
cardiology, Boston Scientific, ICD, clinical trials
FDA Approvals of 2012
FierceMedicalDevice
Thursday, January 3, 2013 - 3:23pm
tags:
FDA, regulatory
Given Imaging Launches New ManoView(TM) ESO v3.0 Software
Yahoo/MarketWire
Thursday, January 3, 2013 - 3:20pm
tags:
Given Imaging, ManoView, software, launch
Masimo iSpO2™ Pulse Oximeter for iOS Platform (iPhone, iPad & iPod touch) for Consumers* to Debut at CES
Yahoo/PRNewswire
Thursday, January 3, 2013 - 3:19pm
tags:
Masimo, iPhone, Apple, pulse oximetry, technology, innovation, devices
ThermoGenesis Announces Sale of Thermoline Product Line to Helmer Scientific
Yahoo/GlobeNewswire
Thursday, January 3, 2013 - 3:17pm
tags:
Thermogenesis, Thermoline, Helmer Scientific, M&A, devices
Abbott wins FDA approval for heart stent
Reuters
Thursday, January 3, 2013 - 3:17pm
tags:
Abbott, FDA, heart, stent, devices
BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial
Yahoo/BusinessWire
Thursday, January 3, 2013 - 3:10pm
tags:
BioMimetic Therapeutics, clinical trials, enrollment, Tendinopathy
Alphatec Spine Receives U.S. FDA 510(K) Market Clearance for Two New Products and Receives Japanese Shonin Approval to Begin Marketing Its Novel(R) Peek Lumbar Spinal Spacers
Yahoo/GlobeNewswire
Thursday, January 3, 2013 - 3:09pm
tags:
Alphatec Spine, FDA, Spinal, devices
Amgen whistleblower can't challenge $612M settlement, judge says
Fierce Pharma
Thursday, January 3, 2013 - 11:57am
tags:
Amgen, whistleblower lawsuits, Aranesp, misbranding
Galena Biopharma Might Soar In 2013
Seeking Alpha
Thursday, January 3, 2013 - 11:47am
tags:
Galena Biopharma
Questcor: How The BioVectra Acquisition Will Help The Company
Seeking Alpha
Thursday, January 3, 2013 - 11:46am
tags:
Questcor, M&A, BioVectra
Repligen will work with Pfizer to develop drug to treat for Spinal Muscular Atrophy
Yahoo/AP
Thursday, January 3, 2013 - 11:41am
tags:
Pfizer, Repligen, spinal muscular atrophy
2 Risks That Could Crush MannKind in 2013
Motley Fool
Thursday, January 3, 2013 - 11:41am
tags:
MannKind, Afrezza
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thursday, January 3, 2013 - 11:39am
tags:
MS, multiple sclerosis, Teva, Copaxone, Rebif, Pfizer, Merck KGaA, Biogen Idec, Avonex, Bayer, Betaseron, Novartis, Extavia, Sanofi, Tysabri, Aubagio, Elan, Gilenya, BG-12
Biogen Sinks as ALS Drug Fails to Show Efficacy in Trial
Bloomberg
Thursday, January 3, 2013 - 11:36am
tags:
ALS, Biogen Idec, dexpramipexole, Lou Gehrig's disease
Novartis’s Lucentis Wins U.K. Backing as Drug’s Price Cut
Bloomberg
Thursday, January 3, 2013 - 11:35am
tags:
UK, Novartis, Lucentis, diabetic macular edema
Bayer's Nexavar meets goal in thyroid cancer trial
Reuters
Thursday, January 3, 2013 - 11:34am
tags:
Bayer, Nexavar, refractory differential thyroid cancer
How Much? Payers And The New Pfizer RA Pill
Pharmalot
Thursday, January 3, 2013 - 11:33am
tags:
Pfizer, rheumatoid arthritis, Xeljanz

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.